CompletedNot Applicable

Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

United States307 participantsStarted 2004-08

Plain-language summary

The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.

Who can participate

Age range21 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: * Female * Urge predominant incontinence * Incontinent \> 3 mos * Available for 8 mos of followup Exclusion: * Pregnancy or \< 6 mos post-partum * Hypersensitivity to drug (tolterodine) * Systemic disease that affects bladder function (e.g., Parkinson's disease, Multiple Sclerosis, spinal cord injury) * History of extensive behavior treatment

What they're measuring

Proportion of Women Who Meet Definition of Success

Timeframe: 8 months

Trial details

NCT IDNCT00090584

SponsorCarelon Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-12

Results submitted2012-08-27

View on ClinicalTrials.gov More Urinary Incontinence (UI) trials